Stay updated on Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe 403 Forbidden page content and its Home navigation text were removed, resulting in the study details page becoming accessible again.SummaryDifference0.5%

- Check24 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content. Access to the study details is blocked and the usual information is not shown.SummaryDifference19%

- Check38 days agoChange DetectedCore topical terms used for indexing were removed from the page's related topics. This narrows the study's indexed associations and could affect discovery for melanoma-related queries.SummaryDifference0.2%

- Check45 days agoChange DetectedMelanoma is added as a related topic and MedlinePlus Genetics is listed under related topics. The page revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check52 days agoChange DetectedThe Melanoma tag, the related topics header, and the MedlinePlus Genetics topic were removed from the study's topics/keywords section.SummaryDifference0.2%

Stay in the know with updates to Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.